Objectives: To investigate the potential beneficial effects of posterior pericardial drainage in patients undergoing heart surgery.
finding during control echocardiography or computed tomography), large effusion may prolong recovery and be life-threatening in case of cardiac tamponade with hemodynamic compromise and/or multiorgan failure. 3 The reported incidence of postoperative pericardial effusion ranges between 1% and 85%, depending on study definitions and designs. [4] [5] [6] In the majority of heart surgery procedures, the pericardium usually is opened longitudinally, because this allows free access to the heart and proximal great vessels. At the end of the procedure, the pericardium usually is left open, although some surgeons choose to close it, except for a small portion at the most caudal part. A second, or auxiliary, incision in the posterior pericardium (Video 1) sometimes is used to facilitate drainage of blood into the pleural cavity, where it can be evacuated with chest tubes. This technique has been shown in nonrandomized trials to reduce the incidence of both postoperative pericardial effusion and postoperative supraventricular tachycardia, 7 suggesting that a large volume of pericardial effusion is one of the main triggers of atrial fibrillation after cardiac surgery. 8 The 2005 American College of Chest Physicians and subsequent 2006 European Association for Cardiothoracic Surgery Guidelines recommended that posterior pericardiotomy (PP) may be a useful, small step to reduce the incidence of postoperative atrial arrhythmias 9, 10 ; however, this recommendation was based on a single, small-scale randomized controlled trial 11 (RCT; strength of recommendation, B; evidence grade, fair; net benefit, intermediate).
PP is not a current standard of care thus far and it is not used widely.
Because of the moderate strength of the recommendations, and because more RCTs that assess safety and efficacy of posterior pericardial drainage have been available since 2006, we performed a systematic review and meta-analysis to investigate whether potential reduction of pericardial effusion and atrial arrhythmias may affect positively the incidence of other potentially lifethreatening conditions.
METHODS Data Sources and Search Strategy
This current systematic review and meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement meta-analyses in health care interventions 12 ; the checklist is available as Table E1 . Relevant RCTs to be included were searched until March 2016 through PubMed, EMBASE, CINAHL, the Web of Science, the Cochrane Register of Controlled Clinical Trials (ie, CENTRAL), and Google Scholar as well as congress proceedings from major cardiac, thoracic, and cardiothoracic, as well as cardiology societies meetings. An exemplary PubMed search strategy is attached as Table E2 . Abstracts were eligible for detailed assessment if available online and reporting outcomes of interest. Search terms were: ''pericardiotomy,'' ''pericardial incision,'' ''pericardial window,'' ''posterior pericardiotomy,'' ''pericardial drainage,'' ''posterior pericardium drainage,'' ''posterior pericardial chest tube,'' ''additional chest tube,'' ''randomized,'' and ''study/trial.'' No language restrictions were imposed. Both blinded and open-label trials were considered eligible. The most updated or inclusive data for each study were used for abstraction. References of original articles and previous meta-analyses were reviewed manually and crosschecked.
Selection Criteria, Quality Assessment, and Outcomes
Studies were included if they met all of the following criteria: (1) RCT; (2) human study; (3) study comparing strategy of posterior pericardial drainage with no intervention to the pericardium during heart surgery; and (4) studies reporting outcomes of interest within the investigated follow-up. Studies were only excluded if they (1) were nonrandomized or (2) had no control group. Narrative reviews, case reports, letters to the editor, etc, were not considered.
Posterior pericardial drainage was defined as (1) PP incision allowing drainage of the pericardial blood/effusion into the pleural cavity; (2) insertion of a chest tube in the posterior pericardium or; (3) both PP and insertion VIDEO 1. Posterior pericardiotomy procedure. The ''inverse T'' incision is performed by the end of the surgical procedure to the posterior aspect of the pericardium. Attention is given not to dissect the phrenic nerve (to the right from the incision site) and that any bleeding vessels from the pericardiotomy site are clipped or meticulously cauterized. Video available at: http://www.jtcvsonline.org/article/S0022-5223 (16) of a chest tube in the pericardium. Patients in the control group underwent no intervention to the posterior pericardium.
Two independent reviewers (M.G. and M.K.) selected the studies for the inclusion and extracted studies and patients characteristics of interest and relevant outcomes. Two authors (M.G. and M.K.) independently assessed the trials' eligibility and risk of bias. Any divergences relative to study inclusion/exclusion or bias assessment were resolved after discussion with the third reviewer (L.A.). The bias risk for randomized studies was assessed by use of the components recommended by the Cochrane Collaboration, 13 ie, random sequence generation and random allocation; allocation concealment; blinding of participants, personnel, and outcome assessors; incomplete outcome data; selective outcome reporting; and other sources of bias. The discrepancies in bias assessment between assessors were recorded and reported as Cohen's kappa. 14 
Endpoints Selection
Primary clinical outcome was in-hospital/30 days' cardiac tamponade defined according to study protocol; remaining outcomes assessed were in-hospital/30 days: death or cardiac arrest; early and late pericardial effusion; postoperative atrial fibrillation (POAF); total chest drainage volume; pleural effusion with or without intervention; reoperation for bleeding; acute kidney injury (AKI); pulmonary complications; and length of intensive care unit and hospital stay. Late pleural effusion could have occurred beyond the investigated follow-up.
Statistical Analysis
Data were analyzed according to intention-to-treat principle wherever applicable. Odds ratios (ORs) and 95% confidence intervals (CIs) served as primary index statistics for dichotomous outcomes; for continuous outcomes, mean difference and corresponding 95% CIs were calculated by the use of a random effects model. To overcome the low statistical power of Cochran Q test, the statistical inconsistency test
, where Q is the c 2 statistic and df its degrees of freedom, was used to assess heterogeneity. 15 It examines the percentage of interstudy variation, with values ranging from 0% to 100%. An I 2 value less than 40% indicated no obvious heterogeneity, values between 40% and 70% were suggestive of moderate heterogeneity, and I 2 > 70% were considered high heterogeneity. Pooled ORs were calculated via the Mantel-Haenszel model with weight assigned to each included study adjusted to include a measure of variation (t 2 ) in the effects reported between studies. This approach estimates the amount of between-study variation by comparing each study's result with a Mantel-Haenszel fixed-effect meta-analysis result and is most conservative in case of low between study heterogeneity. 16 In case the degree of heterogeneity exceeded 40%, an inverse variance (DerSimonian-Laird) random-effects model was applied. As a preferred approach when intervention effects are small (ORs are close to one) and events are not particularly common, estimates were calculated by the use of the fixed-effects Peto method. 17 In case there were ''0 events'' reported in both arms, calculations were repeated, as a sensitivity analysis, by the use of risk difference and respective 95% CIs.
Furthermore, an attempt was made to explore the possible relationship between age, sex, hypertension, type 2 diabetes, type of the surgery, mean number of grafts, duration of cardiopulmonary bypass, crossclamp, and study total number of patients and the occurrence of primary endpoint. Depending on availability of the data, studies were dichotomized separately by these characteristics. The cutoff points were made so as to have equal, or nearly equal, numbers of studies on each side of the dichotomy. Pooled ORs were obtained for each subset of studies and combined in a random-effect meta-analysis. As a sensitivity analysis, the calculations were repeated stratified by the operative technique and after deleting studies, one in a turn, to see whether the results for the primary endpoint were not influenced by single report. In addition, studies not reporting the exact definition/diagnostic criteria for the primary endpoint also were excluded in the sensitivity analysis and estimates recalculated.
Potential publication bias was evaluated by constructing a funnel plot in which the standard error of the log OR was plotted against the OR. The asymmetry of the plot was estimated both visually and by a linear regression approach. 18 Review Manager V.5.1 (The Nordic Cochrane Centre, København, Denmark) and Comprehensive Meta-Analysis, v. 2 (Biostat, Englewood, NJ) were used for statistical computations. P values .05 were considered statistically significant and reported as 2-sided, without adjustment for multiple comparisons.
RESULTS

Study Selection
The study selection process and reasons for exclusion of some studies are described in Figure 1 . A systematic search of the online databases allowed us to collect 37 potentially eligible records that were retrieved for scrutiny. Of those, 18 were further excluded because they were not pertinent to the design of the meta-analysis or did not meet the explicit inclusion criteria. Nineteen RCTs 11, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] that enrolled 3425 patients eventually were included in the analysis. Patients were divided into 2 groups: those with a posterior pericardial drainage (n ¼ 1723) and control group without (n ¼ 1702). In the group of patients who received a posterior pericardial drainage, 1447 patients underwent PP 11, [19] [20] [21] [22] [23] [24] [25] [26] [28] [29] [30] [33] [34] [35] [36] [37] ; in 103 patients, a chest tube was placed within the posterior pericardium 27, 30 ; 173 patients received both PP and posterior pericardium chest tube. 31, 32 On-pump coronary artery bypass grafting (CABG) was the most frequently performed cardiac procedure, 11, 19, 20, 23, 25, 28, [30] [31] [32] [33] [34] [35] [36] followed by combined CABG and/or valve replacement. 21, 22, 24, 37 Two studies reported on patients undergoing valve replacement and/or ascending aorta surgery 26, 27 and another on patients who received offpump CABG alone. 29 Summaries of the studies, as well as patients' baseline characteristics, are reported in Table 1 . Table E3 lists exclusion criteria within single studies; these were predominantly renal dysfunction, endocrine disorders, severe left ventricle dysfunction, history of arrhythmias, and previous cardiac surgery. Definitions or diagnostic criteria for assessed clinical endpoints are listed in Table E4 .
In most studies, 2 drains were placed at the end of surgery: one in the left pleural cavity and the other in the anterior mediastinum, whereas the pericardium was left open anteriorly. PP was performed as described by Mulay and colleagues 38 and comprised a longitudinal, 4-cm long incision parallel and posterior to the phrenic nerve, extending from left inferior pulmonary vein to the diaphragm in most cases. 11, [19] [20] [21] [22] [23] [24] [25] [26] [28] [29] [30] [31] [32] 35, 36 A detailed technique is reported in Table E5 . Table E6 includes an analysis of potential sources of bias for randomized studies using the components recommended by the Cochrane Collaboration. Further publication bias as assessed by funnel plots for the investigated endpoints is shown in Figure E1 , A to H. Two of the included studies reported intervention-related complications: Zhao and colleagues 37 reported one case of postoperative bleeding due to dropping of the hemoclip from the inverse-T incision and Farsak and colleagues 11 reported one case of re-exploration of the grafts because of hemodynamic instability and uncontrollable arrhythmia. The reason was found to be attributable to a protruding sequential vein graft from the pericardiotomy side.
Primary Endpoint
A funnel plot constructed for the primary endpoint revealed signs of moderate asymmetry ( Figure E1 , A), but this was not significant (Egger test, P ¼ .11). Fourteen studies (n ¼ 2844) were included. Individual and overall ORs for cardiac tamponade are depicted in Figure 2 . Posterior pericardial drainage was associated with a significant approximately 90% reduction of the odds of cardiac tamponade compared with the control group: OR (95% CI) 0.13 (0.07-0.25); P <.001; I 2 ¼ 0% in the fixed-effects model.
The corresponding event rates were 0.42% (6/1431) versus 4.95% (70/1413).
Death or Cardiac Arrest
No asymmetry, thus, no signs of publication bias, was noted in the analysis of death or cardiac arrest ( Figure E1 , B). Ten RCTs enrolling 2141 patients provided data for the analysis. The ORs of death or cardiac arrest were significantly decreased by roughly 50% in the posterior pericardial drainage group compared with controls: Peto OR (95% CI): 0.49 (0.25-0.94); P ¼ .03; I 2 ¼ 0%. There were 12 deaths (1.11%) or cardiac arrests compared with 24 (2.26%), respectively, in the posterior pericardial drainage and control groups ( Figure 3 ). Figure E2 ) but was associated with a 64% increase in the OR of pleural effusion managed with or without intervention: OR (95% CI): 1.64 (1.27-2.13); P <.001; I 2 ¼ 1%; and reported in 18.56% and 12.35% of cases in posterior pericardial drainage and control groups, respectively ( Figure E3 ), although there was no difference between posterior pericardial drainage and usual drainage with regard to pulmonary complications: 0.89 (0.65-1.23); P ¼ .48; I 2 ¼ 0% ( Figure E4 ). Similarly, no differences were observed in the incidence of reoperations for bleeding (3 Figure E5 ). Analysis of studies with a focus to the incidence of AKI (4 studies; 816 patients) showed that posterior pericardial drainage compared with the control group was associated with a statistical trend favoring the intervention: Peto OR (95% CI): 0.41 (0.15-1.10); P ¼ .08; I 2 ¼ 5%. Respective event rates were 1.66% (7/421) and 2.78% (11/395) ( Figure E6 ). In addition, although the length of stay in the intensive care unit was not significantly different with either approach (mean difference [95% CI]: 0.03 [À0.21 to 0.28] days; P ¼ .80; I 2 ¼ 64% [ Figure E7 , A]), a significant reduction of nearly 1 day was observed when the overall length of hospital stay was investigated: À0.82 (À1.12 to À0.51) days; P <.001; I 2 ¼ 57% ( Figure E7 , B).
Early and Late Pericardial Effusion
Sensitivity Analyses
In a prespecified subgroup analysis, calculations repeated for the primary endpoint stratified by study/patients' baseline characteristics confirmed the consistency of the effect of posterior pericardial drainage throughout different patient populations, study designs, and operative characteristics. P values for interaction ranged from .20 to .79 ( Figure 6 ). Calculations repeated for the primary endpoint after we accounted for studies reporting ''0 events'' in both arms with risk difference effect measure did not change the direction nor the magnitude of the effect: À0.04 (À0.06 to À0.02; P <.001; I 2 ¼ 64%; Figure E8 ). Additionally performed sensitivity subgroup analysis stratified by the operative technique (PP vs posterior pericardium chest tube vs both) did not reveal any between subgroup interaction and indirectly demonstrated that there were no differences between the approaches to posterior pericardial drainage. (P int ¼ 0.42; Figure E9 ). There was no sign of ''big-study effect'' in the influence analysis performed by deleting studies, one in a turn, and repeating the calculations for the primary endpoint ( Figure E10 ). Similarly, exclusion of studies not reporting the exact definition/diagnostic criteria for the primary endpoint did not alter the final estimates.
DISCUSSION
The current systematic review and meta-analysis of RCTs is the largest database that analyzes the potential beneficial value of a posterior pericardial drainage after heart surgery. The principle finding is the high effectiveness of posterior pericardial drainage in preventing early and late pericardial effusions, cardiac tamponade, and possibly mortality without compromising safety. Posterior pericardial drainage, whether performed by PP, a chest tube to posterior pericardium, or both PP and a chest tube, was demonstrated to (1) significantly reduce the odds of primary endpoint 30-day cardiac tamponade by nearly 90%; (2) significantly reduce the odds of early and late pericardial effusions by 80% and 95%, respectively; (3) significantly reduce the odds of POAF by almost 60%; and (4) significantly shorten the length of hospital stay. In addition, the present metaanalysis with 19 RCTs and 3425 patients is able to demonstrate significantly reduced odds of death or cardiac arrest. A statistical trend towards lesser odds of AKI was shown as well. Although there were no differences regarding the total volume of chest tube drainage, more pleural effusions (requiring intervention or not) were reported in the intervention arm; this, however, did not translate into a greater incidence of pulmonary complications compared with control group.
Delayed-onset pericardial effusion after heart surgery may produce significant morbidity as the result of its presentation as well as management by traditional surgical techniques not uncommonly involving resternotomy. The pericardial fluid collected in a gap in front of the heart usually is drained easily via a chest drain just behind the sternum. In contrast, pericardial adhesions frequently are observed between the inferior and posterior surfaces of the heart and the diaphragm that in turn may create an enclosed gap that makes drainage difficult. The use of pericardiotomy technique enables better drainage of the pericardial fluid and prevents the formation of effusion or tamponade. Typically, PP is performed as a longitudinal, 4-cm long incision parallel and posterior to the phrenic nerve, extending from left inferior pulmonary vein to the diaphragm. 38 This allows unobstructed drainage of the blood and fluids from the pericardium directly to the pleural space. PP is easy to perform and it is cost-effective. Compared with a simple chest tube drainage, however, PP may not be entirely free from intervention-related complications; in addition to a potential risk of cardiac herniation, PP also may exert some adverse influence on bypass grafts as a result of compression by pericardiotomy edges 11, 39 or bleeding from the incision site. 37 These complications may be minimized by performing a limited PP at the end of the procedure at a distance from the bypass grafts.
Meta-analyses of studies conducted so far are not conclusive regarding the prevention of cardiac tamponade, and guidelines recommendations are still weak with regard to routine posterior pericardial drainage. [8] [9] [10] Although partially reflecting the findings of previous reports 7,40 as of reduction of the incidence of POAF, the current metaanalysis with 19 RCTs and 3425 patients represents the most robust data source suggesting significantly reduced odds of cardiac tamponade after posterior pericardial drainage. It represents a good report to show consistent extent of this benefit regardless of patients' baseline risk characteristics. In addition, this study is the first to suggest that benefit in terms of reduced incidence of cardiac tamponade translated into lower odds of mortality or cardiac arrest.
Several mechanisms are speculated to predispose to POAF. Among them is a hypothesis that a certain amount of fluid/hematoma into the pericardium may represent a mechanical irritating stimulus to the atria, whose function can be affected by external compression. In the first prospective study designed to assess safety and effectiveness of PP in reduction of the incidence of pericardial effusion and, consequently, reducing the incidence of supraventricular arrhythmias in the postoperative period, Mulay and colleagues 38 reported the incidence of pericardial effusion in 4 of 50 patients after a PP, whereas effusion occurred in 20 of 50 patients in whom a pericardiotomy was not created (P < .0005). The following studies have confirmed these findings; a randomized study by Kuralay and colleagues 35 showed statistically significant difference in both early (1 vs 54 patients; P < .001) and late pericardial effusion (defined as occurring more than 30 days after operation) (0 vs 21 patients; P <.001). In addition, nearly half (10 of 21) of the patients presenting with delayed pericardial effusion developed pericardial tamponade (P ¼ .01).
Because of the limited size and thus statistical power of the next studies to come, several meta-analyses have addressed the efficacy of PP and development of both arrhythmias and pericardial effusion. Biancari and colleagues, 41 in a meta-analysis of 6 RCTs reporting on POAF in 763 patients after CABG, demonstrated that the cumulative incidence of atrial fibrillation was 10.8% in the PP and 28.1% in the control group (OR, 0.33; 95% CI, 0.16-0.69]; P ¼ .003). To our knowledge, the most recent meta-analysis 42 available, including 10 RCTs and 1648 patients, reported the cumulative incidence of atrial fibrillation of 10.6% in the PP and 24.9% in the control group, respectively (OR, 0.36; 95% CI, 0.23-0.56; P <.001).
A present meta-analysis corroborates previous findings on a larger scale; probably as the result of more extensive and systematic search and no publication language restrictions, 17 RCTs with more than 3200 patients were included for the analysis of POAF; odds were significantly reduced in FIGURE 6 . Subgroup analysis conducted for the primary endpoint cardiac tamponade stratified by patients' baseline-and procedural characteristics (age, sex, hypertension, diabetes, type of surgery, number of grafts, duration of CPB and crossclamp, and number of patients within the study). OR, Odds ratio; 95% CI, 95% confidence interval; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; X-clamp, crossclamp.
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In the present meta-analysis, we assessed safety and efficacy of posterior pericardial drainage compared with control regardless whether it was performed by PP, chest tube to posterior pericardium, or both PP and a chest tube. A number of surgeons do routinely place a posterior pericardial tube (usually soft flexible rubber tube) in addition to an anterior mediastinal tube in the same time avoiding potential risk of PP-related complications. Yet, no consensus exists on the required duration of such drainage 27, 30 and its efficacy in preventing particularly delayed cardiac tamponade. In a subgroup analysis stratified by operative technique, we demonstrated that there were no statistically significant differences between the technical approaches to posterior pericardial drainage in regard to the risk of primary endpoint. Such an indirect comparison was, however, not the principal objective of the current investigation.
Limitations
Several shortcoming of the current analysis should be acknowledged. First, the present analysis shares also the limitations of original studies. The results were therefore analyzed on a trial and not patient level. Given heterogeneity in the study protocols, clinically relevant differences could have been missed and would have been better assessed in a meta-analysis of individual patient data. Second, the present meta-analysis is limited by inclusion of studies that, although randomized, are of suboptimal methodological quality. Indeed, none of the studies provided a detailed randomization protocol. Same uncertainty applies to randomization concealment and incomplete outcome data reporting. Although the vast majority of included studies reported in-hospital mortality, only 5 reported the incidence of neurologic complications, which are essential in studies directed at reducing the incidence of POAF. More importantly, baseline drugs, for instance, oral anticoagulants, antiplatelet therapies, antiarrhythmic drugs, or prophylaxis for atrial fibrillation in early postoperative period, were seldom reported. Small number of studies available for inclusion along with small number of participants poses another limitation; indeed, the largest study analyzed included only 458 patients, and 6 studies included 100 or fewer patients. We accounted for bias and excluded studies at high risk in the sensitivity analysis for the primary endpoint.
CONCLUSIONS
Posterior pericardial drainage is technically easy to perform and represents a safe and effective technique that significantly reduces not only the prevalence of early pericardial effusion and related POAF but also delayed pericardial effusion and cardiac tamponade. These benefits, in turn, translate into lower odds of AKI and improved survival after heart surgery.
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FIGURE E8. Sensitivity analysis conducted for the primary endpoint after accounting for studies reporting 0 events. The individual and overall estimates are expressed as risk difference and 95% CIs. M-H, Mantel-Haenszel; CI, confidence interval. FIGURE E9. Sensitivity subgroup analysis for the comparison between posterior pericardial drainage (intervention) and control group stratified by operative technique conducted for the primary endpoint. The added total number of patients is greater than 3425 because of exact same control groups in one study. 30 IV, Inverse variance; CI, confidence interval.
FIGURE E10
. Sensitivity analysis (influence analysis) for the primary endpoint conducted by deleting each study at a time and repeating the calculations. Analysis shows that no single study has influenced the overall effect of the intervention. CI, Confidence interval. 
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Appendix
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. Pericardial incision AND randomized 24 5 Pericardial window 760 6
Pericardial window AND randomized 6 7 Posterior pericardiotomy 73 8
Posterior pericardiotomy AND randomized 22 9 Pericardial drainage 2222 10
Pericardial drainage AND randomized 57 11
Posterior pericardium drainage 34 12 Posterior pericardium drainage AND randomized 2 13 Posterior pericardial chest tube 10 14 Posterior pericardial chest tube AND randomized 1 15 Additional chest tube 480 16 Additional chest tube AND randomized 57 A longitudinal, 4-cm long incision parallel and posterior to the phrenic nerve, extending from left inferior pulmonary vein to the diaphragm.
Ekim and colleagues 25 Two drains in both groups, one in the left pleural cavity and the other in the anterior mediastinum.
A longitudinal, 4-cm long incision parallel and posterior to the phrenic nerve, extending from left inferior pulmonary vein to the diaphragm. Erdil and colleagues 26 Two drains in study group, one in the left pleural cavity and the other in the anterior mediastinum. One drain in the control group positioned in the anterior mediastinum.
A longitudinal, 4-cm long incision parallel and posterior to the phrenic nerve, extending from left inferior pulmonary vein to the diaphragm.
Eryilmaz and colleagues 27 Two drains in study group, one in the anterior mediastinum and the other (thin closed-suction drain system) behind the heart. One drain in control group: anterior mediastinum plus another drain in both group when left or right pleura was opened. A longitudinal, 4-cm long incision parallel and posterior to the phrenic nerve, extending from left inferior pulmonary vein to the diaphragm. The left pleural cavity was opened.
Kaya and colleagues 31 Three drains in study group, one in the left pleural cavity, one in the anterior mediastinum and the other in the pericardial sac along the right atrium. Pericardium was closed. Two drains in control group. Left pleural cavity and anterior mediastinum. Pericardium left open (2 cm).
A longitudinal, 4-cm long incision parallel and posterior to the phrenic nerve, extending from left inferior pulmonary vein to the diaphragm. 
